Cerecor completes acquisition of Pennsylvania biopharma

Maryland biopharmaceutical company Cerecor Inc. has completed its acquisition of Wayne, Pennsylvania-based Aevi Genomic Medicine Inc. in a transaction involving two companies both focused on developing new therapies for rare pediatric diseases. The all-stock deal, first disclosed in December, carries a value up to $22.1 million. Aevi shareholders received $15.6 million in Cerecor (NASDAQ: CERC) stock, plus the potential for up to another $6.5 million in conditional payments. Those payments include…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news